Mbx Biosciences, Inc To Start Trading Tomorrow

MBX Biosciences, Inc MBX IPO will take place September, 13 on the NASDAQ exchange under the ticker MBX.

The company is offering shares at an expected price between $14.00 and $16.00 per share with an insider lock-up period of 180 days ending on March 12, 2025.

See also: Benzinga IPO Calendar

About MBX Biosciences, Inc

MBX Biosciences, Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders.

See also: Benzinga's Most Shorted Stocks

This article was generated by Benzinga's automated content engine and reviewed by an editor.